Bhutan vs Kuwait: The number of people with susceptibility test result for rifampicin
Bhutan
419
in 2021
Kuwait
401
in 2021
Bhutan rank
83rd
Kuwait rank
85th
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Kuwait
How they compare
Bhutan currently reports 419 against 401 in Kuwait, a difference of 18.
Across all 5 years both countries report, Bhutan has been ahead every year.
Bhutan ranks 83rd and Kuwait ranks 85th of 155 countries.
Bhutan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 400.33 | 346.33 | 54 | Bhutan |
| 2020s | 426.5 | 350 | 76.5 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Kuwait?
- Bhutan, at 419 against 401 in Kuwait as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Kuwait?
- 18, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Kuwait?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Kuwait rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 83rd and Kuwait ranks 85th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.